Arcellx, Inc. Balance Sheet
ACLX / Health Care|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Arcellx, Inc. had $604M in total assets and $402M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $80.3M | $105.7M | $394.6M | $64.2M | $30.8M |
| Current Assets | $462.2M | $599.3M | $716.4M | $266.9M | $112.8M |
| PP&E (Net) | $42.6M | $46.5M | $42.7M | $11.2M | $10.3M |
| Total Assets | $604.0M | $711.3M | $825.1M | $313.8M | $128.8M |
| Current Liabilities | $104.2M | $125.4M | $118.2M | $56.7M | $14.8M |
| Shareholders' Equity | $402.4M | $454.8M | $485.4M | -$205.0M | -$121.5M |